FDA Compliance for Peptide Therapy and BPC 157 Holt Law In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Gray Market Peptides: So Much Hype, So Little Data FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The peptide problem: Hype is outrunning the evidence Demand for Unapproved Weight Loss Drug Surges on Social Media MedPage Today